NDAINTRATHECALSOLUTION
Approved
Sep 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Data completeness
5/8 — Partial
CLOROTEKAL (chloroprocaine hydrochloride) by B. Braun is clinical pharmacology chloroprocaine, like other local anesthetics, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the action potential. Approved for transient neurological symptoms. First approved in 2017.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CLOROTEKAL (chloroprocaine hydrochloride) is a rapid-onset local anesthetic administered via intrathecal injection for transient neurological symptoms. It works by blocking nerve impulse generation and conduction, with onset typically within 6-12 minutes and duration up to 60 minutes. The drug is a small-molecule ester local anesthetic used in neuraxial anesthesia procedures.
Peak7.6 years to LOE
Product is at peak lifecycle stage with stable positioning; commercial teams likely focused on market maintenance and physician engagement in surgical anesthesia settings.
Mechanism of Action
CLINICAL PHARMACOLOGY Chloroprocaine, like other local anesthetics, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the…
Worked on CLOROTEKAL at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.